"Thomas E. Starzl Transplantation Institute is a medical center located in Pittsburgh.Visit our website to learn more about the conditions we treat and the services we offer. Schedule your appointment today. UPMC is committed to protecting our communities from the spread of COVID-19. We continue to require people who come to any UPMC facility to wear a facemask that covers their nose and mouth and to practice other preventative efforts like social distancing, even if fully vaccinated."

During the past decade, UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute" are "Nonalcoholic Steatohepatitis" (4 trials), "Compensated Cirrhosis" (1 trials), "Nonalcoholic Fatty Liver Disease" (1 trials) and "Nonalcoholic Steatohepatitis With Liver Fibrosis" (1 trials). Many other conditions were trialed in "UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute" in a lesser frequency.

Most popular intervention types in "UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "SEL" (3 trials), "Placebo" (2 trials), "Placebo to match SEL 18 mg" (2 trials), "Placebo to match SEL 6 mg" (2 trials) and "CILO" (1 trials). Other intervention names were less common.

The vast majority of trials in "UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC - Center for Liver Diseases at the Thomas E. Starlz Institute, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".